Josan et al., 2011 - Google Patents
Fluorescent and lanthanide labeling for ligand screens, assays, and imagingJosan et al., 2011
View PDF- Document ID
- 2607081238212257906
- Author
- Josan J
- De Silva C
- Yoo B
- Lynch R
- Pagel M
- Vagner J
- Hruby V
- Publication year
- Publication venue
- Drug Design and Discovery: Methods and Protocols
External Links
Snippet
The use of fluorescent (or luminescent) and metal contrast agents in high-throughput screens, in vitro assays, and molecular imaging procedures has rapidly expanded in recent years. Here we describe the development and utility of high-affinity ligands for cancer …
- 230000027455 binding 0 title abstract description 133
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Licha et al. | Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes | |
| JP2020500863A (en) | Inhibitor-functionalized ultra-small nanoparticles and methods thereof | |
| US9642922B2 (en) | Caspase-triggered nano-aggregation probes and methods of use | |
| CN107652358A (en) | A kind of uPAR targeted polypeptides, probe and living body molecule developing method | |
| Josan et al. | Fluorescent and lanthanide labeling for ligand screens, assays, and imaging | |
| US8834844B2 (en) | Chemical exchange saturation transfer based MRI using reporter genes and MRI methods related thereto | |
| CN110845572A (en) | Tumor-targeted GRP analogs and their applications | |
| Fan et al. | Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer | |
| US9200017B2 (en) | Multimodal imaging of fibrin | |
| WO2010009246A2 (en) | Methods and reagents for preparing multifunctional probes | |
| US11389551B2 (en) | Polarisation transfer via a second metal complex | |
| CN118240017A (en) | A tumor tissue affinity peptide and its application | |
| Huang et al. | Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging | |
| Sun et al. | A near-infrared fluorescent probe with assembly/aggregation-induced retention effect for specific diagnosis of metastasis and image-guided surgery in breast cancer | |
| CN112933249A (en) | PD-L1 targeted bimodal molecular probe and preparation method and application thereof | |
| Lins et al. | Parahydrogen-induced polarization allows 2000-fold signal enhancement in biologically active derivatives of the peptide-based drug octreotide | |
| Song et al. | Bioconjugates of versatile β-diketonate–lanthanide complexes as probes for time-gated luminescence and magnetic resonance imaging of cancer cells in vitro and in vivo | |
| US20160051704A1 (en) | Molecular imaging probes for lung cancer intraoperative guidance | |
| Yang et al. | Design, synthesis, and in vitro evaluation of a binary targeting MRI contrast agent for imaging tumor cells | |
| US9585975B2 (en) | MRI contrast agents | |
| Konishi et al. | Development of off-on switching 19F MRI probes for cathepsin K activity detection | |
| CN107522773B (en) | A kind of pentapeptide modified rhodamine B compound and its preparation method and application | |
| CN114632079B (en) | Preparation and application of iron pool targeting molecule image probe based on artemisinin | |
| CN116547293A (en) | Radioactive metal complex for targeting prostate specific membrane antigen and labeled ligand thereof | |
| US9889213B2 (en) | Multimodal imaging of fibrin |